ミカファンギンの米国市場

【英語タイトル】United States Micafungin Market Insights, Forecast to 2027

QYResearchが出版した調査資料(RG-001495-US)・商品コード:RG-001495-US
・発行会社(調査会社):QYResearch
・発行日:2021年11月(※2024年版があります。お問い合わせください。)
・ページ数:約110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:米国
・産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,200 ⇒換算¥473,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,800 ⇒換算¥710,400見積依頼/購入/質問フォーム
Enterprise License(法人閲覧用)USD6,400 ⇒換算¥947,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

The United States Micafungin market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX during 2021-2027.
Micafungin market is segmented by type, and by application. Players, stakeholders, and other participants in the United States Micafungin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by type, and by application for the period 2016-2027.

Segment by Type
 50 mg Single-use Vial
 100 mg Single-use Vial

Segment by Application
 Candidemia
 Respiratory Mycosis
 Gastrointestinal Mycosis

By Company
 Astellas
 Endo International
 Xellia Pharmaceuticals
 Teva
 Hikma
 Apotex

❖ レポートの目次 ❖

1 STUDY COVERAGE
1.1 Micafungin Product Introduction
1.2 Market by Type
1.2.1 United States Micafungin Market Size Growth Rate by Type
1.2.2 50 mg Single-use Vial
1.2.3 100 mg Single-use Vial
1.3 Market by Application
1.3.1 United States Micafungin Market Size Growth Rate by Application
1.3.2 Candidemia
1.3.3 Respiratory Mycosis
1.3.4 Gastrointestinal Mycosis
1.4 United States Micafungin Market Size Estimates and Forecasts
1.4.1 United States Micafungin Sales Estimates and Forecasts 2016-2027
1.4.2 United States Micafungin Revenue Estimates and Forecasts 2016-2027
1.5 Study Objectives
1.6 Years Considered
2 COMPETITION BY MANUFACTURER
2.1 United States Micafungin Sales by Manufacturer
2.1.1 United States Micafungin Sales by Manufacturer (2016-2021)
2.1.2 United States Micafungin Manufacturers Market Share by Sales (2016-2021)
2.1.3 United States 3 and Top 5 Companies by Micafungin Sales in 2020
2.2 United States Micafungin Revenue by Manufacturer
2.2.1 United States Micafungin Manufacturers by Revenue (2016-2021)
2.2.2 United States Micafungin Manufacturers Market Share by Revenue (2016-2021)
2.2.3 United States 3 and Top 5 Companies by Micafungin Revenue in 2020
2.3 United States Micafungin Sales Price by Manufacturer
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.4.2 United States Micafungin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Micafungin Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3 MARKET SIZE BY TYPE
3.1 United States Micafungin Sales by Type
3.1.1 United States Micafungin Historical Sales by Type (2016-2021)
3.1.2 United States Micafungin Forecasted Sales by Type (2022-2027)
3.1.3 United States Micafungin Sales Market Share by Type (2016-2027)
3.2 United States Micafungin Revenue by Type
3.2.1 United States Micafungin Historical Revenue by Type (2016-2021)
3.2.2 United States Micafungin Forecasted Revenue by Type (2022-2027)
3.2.3 United States Micafungin Revenue Market Share by Type (2016-2027)
3.3 United States Micafungin Price by Type
3.3.1 United States Micafungin Price by Type (2016-2021)
3.3.2 United States Micafungin Price Forecast by Type (2022-2027)
4 MARKET SIZE BY APPLICATION
4.1 United States Micafungin Sales by Application
4.1.1 United States Micafungin Historical Sales by Application (2016-2021)
4.1.2 United States Micafungin Forecasted Sales by Application (2022-2027)
4.1.3 United States Micafungin Sales Market Share by Application (2016-2027)
4.2 United States Micafungin Revenue by Application
4.2.1 United States Micafungin Historical Revenue by Application (2016-2021)
4.2.2 United States Micafungin Forecasted Revenue by Application (2022-2027)
4.2.3 United States Micafungin Revenue Market Share by Application (2016-2027)
4.3 United States Micafungin Price by Application
4.3.1 United States Micafungin Price by Application (2016-2021)
4.3.2 United States Micafungin Price Forecast by Application (2022-2027)
5 CORPORATE PROFILE
5.1 Astellas
5.1.1 Astellas Corporation Information
5.1.2 Astellas Overview
5.1.3 Astellas in United States: Micafungin Sales, Price, Revenue and Gross Margin (2016-2021)
5.1.4 Astellas Micafungin Product Description
5.1.5 Astellas Recent Developments
5.2 Endo International
5.2.1 Endo International Corporation Information
5.2.2 Endo International Overview
5.2.3 Endo International in United States: Micafungin Sales, Price, Revenue and Gross Margin (2016-2021)
5.2.4 Endo International Micafungin Product Description
5.2.5 Endo International Recent Developments
5.3 Xellia Pharmaceuticals
5.3.1 Xellia Pharmaceuticals Corporation Information
5.3.2 Xellia Pharmaceuticals Overview
5.3.3 Xellia Pharmaceuticals in United States: Micafungin Sales, Price, Revenue and Gross Margin (2016-2021)
5.3.4 Xellia Pharmaceuticals Micafungin Product Description
5.3.5 Xellia Pharmaceuticals Recent Developments
5.4 Teva
5.4.1 Teva Corporation Information
5.4.2 Teva Overview
5.4.3 Teva in United States: Micafungin Sales, Price, Revenue and Gross Margin (2016-2021)
5.4.4 Teva Micafungin Product Description
5.4.5 Teva Recent Developments
5.5 Hikma
5.5.1 Hikma Corporation Information
5.5.2 Hikma Overview
5.5.3 Hikma in United States: Micafungin Sales, Price, Revenue and Gross Margin (2016-2021)
5.5.4 Hikma Micafungin Product Description
5.5.5 Hikma Recent Developments
5.6 Apotex
5.6.1 Apotex Corporation Information
5.6.2 Apotex Overview
5.6.3 Apotex in United States: Micafungin Sales, Price, Revenue and Gross Margin (2016-2021)
5.6.4 Apotex Micafungin Product Description
5.6.5 Apotex Recent Developments
6 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
6.1 Micafungin Industry Chain Analysis
6.2 Micafungin Key Raw Materials
6.2.1 Key Raw Materials
6.2.2 Raw Materials Key Suppliers
6.3 Micafungin Production Mode & Process
6.4 Micafungin Sales and Marketing
6.4.1 Micafungin Sales Channels
6.4.2 Micafungin Distributors
6.5 Micafungin Customers
7 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS
7.1 Micafungin Industry Trends
7.2 Micafungin Market Drivers
7.3 Micafungin Market Challenges
7.4 Micafungin Market Restraints
8 KEY FINDINGS IN THE UNITED STATES MICAFUNGIN STUDY
9 APPENDIX
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES
Table 1. United States Micafungin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 100 mg Single-use Vial
Table 3. United States Micafungin Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 4. United States Micafungin Sales by Manufacturer (2016-2021) & (K Units)
Table 5. United States Micafungin Sales Share by Manufacturer (2016-2021)
Table 6. United States Micafungin Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 7. United States Micafungin Revenue Share by Manufacturer (2016-2021)
Table 8. Micafungin Price by Manufacturer 2016-2021 (USD/Unit)
Table 9. United States Micafungin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 10. United States Micafungin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Micafungin as of 2020)
Table 11. Micafungin Manufacturing Base Distribution and Headquarters
Table 12. Manufacturers Micafungin Product Offered
Table 13. Date of Manufacturers Enter into Micafungin Market
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. United States Micafungin Sales by Type (2016-2021) & (K Units)
Table 16. United States Micafungin Sales by Type (2022-2027) & (K Units)
Table 17. United States Micafungin Sales Share by Type (2016-2021)
Table 18. United States Micafungin Sales Share by Type (2022-2027)
Table 19. United States Micafungin Revenue by Type (2016-2021) & (US$ Million)
Table 20. United States Micafungin Revenue by Type (2022-2027) & (US$ Million)
Table 21. United States Micafungin Revenue Share by Type (2016-2021)
Table 22. United States Micafungin Revenue Share by Type (2022-2027)
Table 23. Micafungin Price by Type (2016-2021) & (USD/Unit)
Table 24. United States Micafungin Price Forecast by Type (2022-2027) & (USD/Unit)
Table 25. United States Micafungin Sales by Application (2016-2021) & (K Units)
Table 26. United States Micafungin Sales by Application (2022-2027) & (K Units)
Table 27. United States Micafungin Sales Share by Application (2016-2021)
Table 28. United States Micafungin Sales Share by Application (2022-2027)
Table 29. United States Micafungin Revenue by Application (2016-2021) & (US$ Million)
Table 30. United States Micafungin Revenue by Application (2022-2027) & (US$ Million)
Table 31. United States Micafungin Revenue Share by Application (2016-2021)
Table 32. United States Micafungin Revenue Share by Application (2022-2027)
Table 33. Micafungin Price by Application (2016-2021) & (USD/Unit)
Table 34. United States Micafungin Price Forecast by Application (2022-2027) & (USD/Unit)
Table 35. Astellas Corporation Information
Table 36. Astellas Description and Major Businesses
Table 37. Astellas Micafungin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 38. Astellas Micafungin Product
Table 39. Astellas Recent Developments
Table 40. Endo International Corporation Information
Table 41. Endo International Description and Major Businesses
Table 42. Endo International Micafungin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 43. Endo International Micafungin Product
Table 44. Endo International Recent Developments
Table 45. Xellia Pharmaceuticals Corporation Information
Table 46. Xellia Pharmaceuticals Description and Major Businesses
Table 47. Xellia Pharmaceuticals Micafungin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 48. Xellia Pharmaceuticals Micafungin Product
Table 49. Xellia Pharmaceuticals Recent Developments
Table 50. Teva Corporation Information
Table 51. Teva Description and Major Businesses
Table 52. Teva Micafungin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 53. Teva Micafungin Product
Table 54. Teva Recent Developments
Table 55. Hikma Corporation Information
Table 56. Hikma Description and Major Businesses
Table 57. Hikma Micafungin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 58. Hikma Micafungin Product
Table 59. Hikma Recent Developments
Table 60. Apotex Corporation Information
Table 61. Apotex Description and Major Businesses
Table 62. Apotex Micafungin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 63. Apotex Micafungin Product
Table 64. Apotex Recent Developments
Table 65. Key Raw Materials Lists
Table 66. Raw Materials Key Suppliers Lists
Table 67. Micafungin Distributors List
Table 68. Micafungin Customers List
Table 69. Micafungin Market Trends
Table 70. Micafungin Market Drivers
Table 71. Micafungin Market Challenges
Table 72. Micafungin Market Restraints
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources



★調査レポート[ミカファンギンの米国市場] (コード:RG-001495-US)販売に関する免責事項を必ずご確認ください。
★調査レポート[ミカファンギンの米国市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆